Cargando…
Metabolic derangements with olanzapine and risperidone in schizophrenia spectrum and other psychotic disorders: A 24-week prospective study
BACKGROUND AND AIMS: Schizophrenia spectrum and other psychotic disorders are common disorders often requiring long-term treatment with atypical antipsychotics, which might cause metabolic dysfunctions. We aimed to study the metabolic dysfunctions with olanzapine and risperidone in patients with sch...
Autores principales: | Rikhari, Praveen, Kumar, Ashutosh, Agrawal, Prabhat, Kumar, Harendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254779/ https://www.ncbi.nlm.nih.gov/pubmed/35800481 http://dx.doi.org/10.4103/jfmpc.jfmpc_2161_21 |
Ejemplares similares
-
Olanzapine has better efficacy compared to risperidone for treatment of negative symptoms in schizophrenia
por: Suresh Kumar, P. N., et al.
Publicado: (2016) -
A Comparative Study between Olanzapine and Risperidone in the Management of Schizophrenia
por: Shoja Shafti, Saeed, et al.
Publicado: (2014) -
Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study
por: Gabriel, A
Publicado: (2013) -
Therapeutic drug monitoring in children and adolescents with schizophrenia and other psychotic disorders using risperidone
por: Taurines, R., et al.
Publicado: (2022) -
Sexual dysfunction in male schizophrenia remitted patients treated with risperidone and olanzapine
Publicado: (2022)